MARKET

SNSS

SNSS

Sunesis Pharma
NASDAQ

Real-time Quotes | Nasdaq Last Sale

0.5573
-0.0127
-2.23%
After Hours: 0.5700 +0.0127 +2.28% 19:20 01/17 EST
OPEN
0.5839
PREV CLOSE
0.5700
HIGH
0.6150
LOW
0.5130
VOLUME
2.81M
TURNOVER
--
52 WEEK HIGH
1.770
52 WEEK LOW
0.1951
MARKET CAP
62.04M
P/E (TTM)
-1.3856
1D
5D
1M
3M
1Y
5Y

Buy or sell shares of SNSS and other stocks commission-free!

Open a Webull account and fund it to get a free stock

Analyst Rating

Based on 4 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

EPS

SNSS News

  • Is Sunesis Pharmaceuticals, Inc. (SNSS) Going To Burn These Hedge Funds ?
  • Insider Monkey.12/19/2019 23:10
  • Sunesis Pharmaceuticals (SNSS) Investor Presentation - Slideshow
  • Seeking Alpha - Article.12/11/2019 17:28
  • The Week Ahead In Biotech: ASH Presentations Pick Up Steam, Correvio Awaits Adcom Ruling
  • Benzinga.12/07/2019 13:35
  • The Week Ahead In Biotech: ASH Presentations Pick Up Steam, Correvio Awaits Adcom Ruling
  • Benzinga.12/07/2019 13:35

More

Industry

Biotechnology & Medical Research
-0.10%
Pharmaceuticals & Medical Research
+0.07%

Hot Stocks

Name
Price
%Change

About SNSS

Sunesis Pharmaceuticals, Inc. is a biopharmaceutical company. The Company focuses on the development and commercialization of its pipeline of oncology therapeutics for the treatment of solid and hematologic cancers. The Company’s lead programs are Vecabrutinib, SNS-510 and TAK-580. The Company also offers Vosaroxin, an anticancer quinolone derivative (AQD), which is used for the treatment of acute myeloid leukemia (AML). Vecabrutinib is a selective, reversible, non-covalent binding inhibitor of Bruton's tyrosine kinase (BTK) inhibitors. SNS-510 is a phosphoinositide dependent protein kinase 1 (PDK1) inhibitors. TAK-580 is an oral, investigative drug selective for pan-Raf kinase inhibition, in patients with relapsed or refractory solid tumors.
More

Webull offers Sunesis Pharmaceuticals, Inc. (SNSS) stock price, real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, stock news, and many more online research tools to help you make informed decisions.